These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28368470)

  • 1. 11β-HSD1 Modulates the Set Point of Brown Adipose Tissue Response to Glucocorticoids in Male Mice.
    Doig CL; Fletcher RS; Morgan SA; McCabe EL; Larner DP; Tomlinson JW; Stewart PM; Philp A; Lavery GG
    Endocrinology; 2017 Jun; 158(6):1964-1976. PubMed ID: 28368470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential roles of 11β-HSD1 in regulating brown adipocyte function.
    Liu J; Kong X; Wang L; Qi H; Di W; Zhang X; Wu L; Chen X; Yu J; Zha J; Lv S; Zhang A; Cheng P; Hu M; Li Y; Bi J; Li Y; Hu F; Zhong Y; Xu Y; Ding G
    J Mol Endocrinol; 2013 Feb; 50(1):103-13. PubMed ID: 23197361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
    Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11β-Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammation.
    Hardy RS; Doig CL; Hussain Z; O'Leary M; Morgan SA; Pearson MJ; Naylor A; Jones SW; Filer A; Stewart PM; Buckley CD; Lavery GG; Cooper MS; Raza K
    J Pathol; 2016 Dec; 240(4):472-483. PubMed ID: 27578244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess.
    Morgan SA; McCabe EL; Gathercole LL; Hassan-Smith ZK; Larner DP; Bujalska IJ; Stewart PM; Tomlinson JW; Lavery GG
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):E2482-91. PubMed ID: 24889609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.
    Lavery GG; Zielinska AE; Gathercole LL; Hughes B; Semjonous N; Guest P; Saqib K; Sherlock M; Reynolds G; Morgan SA; Tomlinson JW; Walker EA; Rabbitt EH; Stewart PM
    Endocrinology; 2012 Jul; 153(7):3236-48. PubMed ID: 22555437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects.
    Tiganescu A; Tahrani AA; Morgan SA; Otranto M; Desmoulière A; Abrahams L; Hassan-Smith Z; Walker EA; Rabbitt EH; Cooper MS; Amrein K; Lavery GG; Stewart PM
    J Clin Invest; 2013 Jul; 123(7):3051-60. PubMed ID: 23722901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
    Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
    Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy.
    Fenton CG; Doig CL; Fareed S; Naylor A; Morrell AP; Addison O; Wehmeyer C; Buckley CD; Cooper MS; Lavery GG; Raza K; Hardy RS
    Arthritis Res Ther; 2019 Aug; 21(1):188. PubMed ID: 31420008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
    Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
    Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo.
    De Sousa Peixoto RA; Turban S; Battle JH; Chapman KE; Seckl JR; Morton NM
    Endocrinology; 2008 Apr; 149(4):1861-8. PubMed ID: 18174284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of adipocyte 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) by CCAAT/enhancer-binding protein (C/EBP) β isoforms, LIP and LAP.
    Esteves CL; Kelly V; Bégay V; Man TY; Morton NM; Leutz A; Seckl JR; Chapman KE
    PLoS One; 2012; 7(5):e37953. PubMed ID: 22662254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brown adipose tissue remodelling induced by corticosterone in male Wistar rats.
    Mousovich-Neto F; Matos MS; Costa ACR; de Melo Reis RA; Atella GC; Miranda-Alves L; Carvalho DP; Ketzer LA; Corrêa da Costa VM
    Exp Physiol; 2019 Apr; 104(4):514-528. PubMed ID: 30653762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11β-hydroxysteroid dehydrogenase type 1.
    Semjonous NM; Sherlock M; Jeyasuria P; Parker KL; Walker EA; Stewart PM; Lavery GG
    Endocrinology; 2011 Jan; 152(1):93-102. PubMed ID: 21106871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11β-hydroxysteroid dehydrogenase-1 deficiency alters brain energy metabolism in acute systemic inflammation.
    Verma M; Kipari TMJ; Zhang Z; Man TY; Forster T; Homer NZM; Seckl JR; Holmes MC; Chapman KE
    Brain Behav Immun; 2018 Mar; 69():223-234. PubMed ID: 29162555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11β-Hydroxysteroid Dehydrogenase Type 1 within Osteoclasts Mediates the Bone Protective Properties of Therapeutic Corticosteroids in Chronic Inflammation.
    Fenton CG; Crastin A; Martin CS; Suresh S; Montagna I; Hussain B; Naylor AJ; Jones SW; Hansen MS; Gorvin CM; Price M; Filer A; Cooper MS; Lavery GG; Raza K; Hardy RS
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Stimson RH; Walker BR
    Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid hormone (T
    Yau WW; Singh BK; Lesmana R; Zhou J; Sinha RA; Wong KA; Wu Y; Bay BH; Sugii S; Sun L; Yen PM
    Autophagy; 2019 Jan; 15(1):131-150. PubMed ID: 30209975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
    Masuzaki H; Flier JS
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.